Abstract
Respiratory viral infections remain a leading cause of morbidity and mortality. Using a murine model of human metapneumovirus, we identified recruitment of a C1q-expressing inflammatory monocyte population concomitant with viral clearance by adaptive immune cells. Genetic ablation of C1q led to reduced CD81 T-cell function. Production of C1q by a myeloid lineage was necessary to enhance CD81 T-cell function. Activated and dividing CD81 T cells expressed a C1q receptor, gC1qR. Perturbation of gC1qR signaling led to altered CD81 T-cell IFN-g production, metabolic capacity, and cell proliferation. Autopsy specimens from fatal respiratory viral infections in children exhibited diffuse production of C1q by an interstitial population. Humans with severe coronavirus disease (COVID-19) infection also exhibited upregulation of gC1qR on activated and rapidly dividing CD81 T cells. Collectively, these studies implicate C1q production from monocytes as a critical regulator of CD81 T-cell function following respiratory viral infection.
Original language | English (US) |
---|---|
Pages (from-to) | 294-306 |
Number of pages | 13 |
Journal | American journal of respiratory cell and molecular biology |
Volume | 71 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2024 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2024 by the American Thoracic Society.
Keywords
- COVID-19
- antiviral immunity
- complement
- human metapneumovirus
PubMed: MeSH publication types
- Journal Article